Travere Therapeutics, Inc. (TVTX) Social Stream



Travere Therapeutics, Inc. (TVTX): $8.05

0.20 (+2.55%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add TVTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#159 of 360

in industry

TRAVERE THERAPEUTICS INC (TVTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering TRAVERE THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-15 7 $45 $20 $37 $7.64 384.29%
2021-12-16 7 $45 $20 $37.833 $7.64 395.2%
2022-01-10 7 $45 $25 $38.666 $7.64 406.1%
2022-01-25 7 $45 $27 $39 $7.64 410.47%
2022-02-25 7 $45 $27 $37 $7.64 384.29%
2022-02-28 6 $45 $27 $40.285 $7.64 427.29%
2022-03-10 5 $45 $27 $39.5 $7.64 417.02%
2022-04-20 8 $45 $27 $39.857 $7.64 421.69%
2022-04-25 8 $45 $27 $40.714 $7.64 432.91%
2022-04-28 8 $45 $24 $40.875 $7.64 435.01%
2022-05-06 8 $45 $24 $40.5 $7.64 430.1%
2022-05-16 8 $45 $24 $40.25 $7.64 426.83%
2022-05-17 8 $46 $24 $40.375 $7.64 428.47%
2022-06-02 8 $46 $24 $39.714 $7.64 419.82%
2022-06-08 8 $46 $24 $39.571 $7.64 417.95%
2022-06-13 8 $47 $24 $40.142 $7.64 425.42%
2022-07-26 9 $47 $25 $40.625 $7.64 431.74%
2022-08-04 9 $46 $25 $40.625 $7.64 431.74%
2022-08-08 9 $45 $25 $39.375 $7.64 415.38%
2022-09-17 9 $45 $25 $39.125 $7.64 412.11%
2022-10-17 9 $45 $24 $38 $7.64 397.38%
2022-10-21 9 $43 $24 $37.125 $7.64 385.93%
2022-10-28 9 $44 $24 $37.25 $7.64 387.57%
2022-11-03 9 $44 $24 $37.125 $7.64 385.93%
2022-12-05 10 $44 $24 $36.111 $7.64 372.66%
2022-12-14 11 $44 $22 $34.7 $7.64 354.19%
2023-01-26 10 $44 $22 $34.666 $7.64 353.74%
2023-01-30 10 $44 $22 $34.444 $7.64 350.84%
2023-02-01 10 $44 $22 $34.555 $7.64 352.29%
2023-02-16 10 $50 $22 $35.222 $7.64 361.02%
2023-02-21 11 $52 $22 $37.6 $7.64 392.15%
2023-02-26 11 $52 $23 $37.5 $7.64 390.84%
2023-02-28 10 $52 $23 $37.3 $7.64 388.22%
2023-03-01 12 $52 $23 $37.272 $7.64 387.85%
2023-03-14 12 $52 $23 $37 $7.64 384.29%
2023-03-22 11 $52 $23 $36.6 $7.64 379.06%
2023-04-10 11 $52 $23 $36.9 $7.64 382.98%
2023-04-18 11 $52 $23 $36.8 $7.64 381.68%
2023-05-02 11 $43 $23 $32.7 $7.64 328.01%
2023-05-05 12 $43 $16 $29.454 $7.64 285.52%
2023-05-23 13 $42 $16 $28.666 $7.64 275.21%
2023-06-06 13 $42 $16 $29.916 $7.64 291.57%
2023-07-10 14 $42 $16 $29.307 $7.64 283.6%
2023-07-17 13 $42 $16 $29.461 $7.64 285.62%
2023-07-18 14 $41 $16 $28.923 $7.64 278.57%
2023-07-24 15 $41 $16 $28.714 $7.64 275.84%
2023-08-04 15 $41 $17 $28.785 $7.64 276.77%
2023-08-07 15 $41 $17 $28.357 $7.64 271.16%
2023-08-13 15 $41 $17 $28 $7.64 266.49%
2023-08-14 15 $41 $17 $27.785 $7.64 263.68%
2023-08-30 15 $41 $17 $27.571 $7.64 260.88%
2023-09-06 15 $41 $17 $27.857 $7.64 264.62%

The Trend in the Analyst Price Target


Over the past 34 months, TVTX's average price target has gone down $4.03.

TVTX reports an average of 76.15% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-13 10 44 22 34.555 20.32 70.05%
2023-01-26 10 44 22 34.666 21.83 58.8%
2023-01-30 10 44 22 34.444 21.43 60.73%
2023-06-06 14 42 16 29.916 19.34 54.68%
2023-07-21 15 41 16 28.714 16.11 78.24%

TVTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.27 13 0 2 0 0 15

The Trend in the Broker Recommendations


TVTX's average broker recommendation rating worsened by 0.1 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, TRAVERE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 5701.9% of them.
  • TRAVERE THERAPEUTICS INC's number of analysts covering the stock is higher than 5879.86% of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, TRAVERE THERAPEUTICS INC's average analyst price target is greater than 5026.95% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, TRAVERE THERAPEUTICS INC's variance in analysts' estimates is lower than -4200.4% of them.

In the Pharmaceutical Products industry, FBIO, ASMB, and HROW are the three stocks most similar to TRAVERE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for TVTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!